Skip to content
Accessible Unlicensed Requires Authentication Published by De Gruyter October 31, 2019

Prediction of modes of action of components of traditional medicinal preparations

Fatima Baldo
From the journal Physical Sciences Reviews


Traditional medicine preparations are used to treat many ailments in multiple regions across the world. Despite their widespread use, the mode of action of these preparations and their constituents are not fully understood. Traditional methods of elucidating the modes of action of these natural products (NPs) can be expensive and time consuming e. g. biochemical methods, bioactivity guided fractionation, etc. In this review, we discuss some methods for the prediction of the modes of action of traditional medicine preparations, both in mixtures and as isolated NPs. These methods are useful to predict targets of NPs before they are experimentally validated. Case studies of the applications of these methods are also provided herein.

Definitions and abbreviations


Chemical compound or substance produced by a living organism that is found in nature


Traditional African medicine


Traditional Chinese medicine


Traditional Indian medicine


[1] Solecki RS. Shanidar IV, a Neanderthal flower burial in Northern Iraq. Science. 1975;190:880–1.Search in Google Scholar

[2] Sumner J. The natural history of medicinal plants. Portland, Oregon: Timber Press, 2000.Search in Google Scholar

[3] Ebbell B. The Ebers Papyrus. The Greatest Egyptian medical document, vol. 17. London: H. Milford and Oxford University Press, 1937:123.Search in Google Scholar

[4] Elufioye TO, Badal S. Chapter 1 - Background to pharmacognosy. In: Badal S, Delgoda R, editor(s). Pharmacognosy. ed Boston: Academic Press, 2017:3–13.Search in Google Scholar

[5] Baldo F. Integrating chemical, biological and phylogenetic spaces of African natural products to understand their therapeutic activity. Doctor of Philosophy, Cambridge, United Kingdom: Chemistry, University of Cambridge, 2019.Search in Google Scholar

[6] Zheng XS, Chan TF, Zhou HH. Genetic and genomic approaches to identify and study the targets of bioactive small molecules. Chem Biol. 2004;11:609–18.Search in Google Scholar

[7] Boutros M, Ahringer J. The art and design of genetic screens: RNA interference. Nat Rev Genet. 2008;9:554–66.Search in Google Scholar

[8] Wright MH, Sieber SA. Chemical proteomics approaches for identifying the cellular targets of natural products. Nat Prod Rep. 2016;33:681–708.Search in Google Scholar

[9] Amos GC, Awakawa T, Tuttle RN, Letzel A-C, Kim MC, Kudo Y, et al. Comparative transcriptomics as a guide to natural product discovery and biosynthetic gene cluster functionality. Proc Nat Acad Sci. 2017;114:E11121.Search in Google Scholar

[10] Yuliana ND, Khatib A, Choi YH, Verpoorte R. Metabolomics for bioactivity assessment of natural products. Phytother Res. 2011;25:157–69.Search in Google Scholar

[11] Fung S-Y, Sofiyev V, Schneiderman J, Hirschfeld AF, Victor RE, Woods K, et al. Unbiased screening of marine sponge extracts for anti-inflammatory agents combined with chemical genomics identifies girolline as an inhibitor of protein synthesis. ACS Chem Biol. 2014;9:247–57.Search in Google Scholar

[12] Gokgoz NB, Akbulut BS. Proteomics evidence for the activity of the putative antibacterial plant alkaloid (-)-roemerine: Mainstreaming omics-guided drug discovery. Omics. 2015;19:478–89.Search in Google Scholar

[13] Dyshlovoy SA, Otte K, Venz S, Hauschild J, Junker H, Makarieva TN, et al. Proteomic-based investigations on the mode of action of the marine anticancer compound rhizochalinin. Proteomics. 2017;17:1700048Search in Google Scholar

[14] Yu Y, Yi Z-B, Liang Y-Z. Main antimicrobial components of Tinospora capillipes, and their mode of action against Staphylococcus aureus. FEBS Lett. 2007;581:4179–83.Search in Google Scholar

[15] Biao-Yi Z, Yu Y, Zeng-Liang Y. Investigation of antimicrobial model of Hemsleya pengxianensis W.J. Chang and its main active component by metabolomics technique. J Ethnopharmacol. 2008;116:89–95.Search in Google Scholar

[16] Shen F, Tang X, Wang Y, Yang Z, Shi X, Wang C, et al. Phenotype and expression profile analysis of Staphylococcus aureus biofilms and planktonic cells in response to licochalcone A. Appl Microbiol Biotechnol. 2015;99:359–73.Search in Google Scholar

[17] Pan Z, Agarwal AK, Xu T, Feng Q, Baerson SR, Duke SO, et al. Identification of molecular pathways affected by pterostilbene, a natural dimethylether analog of resveratrol. BMC Med Genomics. 2008;1:7–7.Search in Google Scholar

[18] Schenone M, Dancik V, Wagner B, Clemons P. Target identification and mechanism of action in chemical biology and drug discovery. Nat Chem Biol. 2013;9:232–40.Search in Google Scholar

[19] Klopmand G. Concepts and applications of molecular similarity, by Mark A. Johnson and Gerald M. Maggiora, eds., John Wiley & Sons, New York, 1990, 393 pp. Price: $65.00. J Comput Chem. 1992;13:539–40.Search in Google Scholar

[20] Martin YC, Kofron JL, Traphagen LM. Do structurally similar molecules have similar biological activity? J Med Chem. 2002;45:4350–8.Search in Google Scholar

[21] Lin S-K. Pharmacophore perception, development and use in drug design. Edited by Osman F. Güner. Molecules. 2000;5:987.Search in Google Scholar

[22] Laggner C, Schieferer C, Fiechtner B, Poles G, Hoffmann RD, Glossmann H, et al. Discovery of high-affinity ligands of sigma1 receptor, ERG2, and emopamil binding protein by pharmacophore modeling and virtual screening. J Med Chem. 2005;48:4754–64.Search in Google Scholar

[23] Rollinger JM, Schuster D, Danzl B, Schwaiger S, Markt P, Schmidtke M, et al. In silico target fishing for rationalized ligand discovery exemplified on constituents of Ruta graveolens. Planta Med. 2009;75:195–204.Search in Google Scholar

[24] Jitender V, Vijay MK, Evans CC. 3D-QSAR in drug design - A review. Curr Top Med Chem. 2010;10:95–115.Search in Google Scholar

[25] Chen G, Zhou D, Li X-Z, Jiang Z, Tan C, Wei X-Y, et al. A natural chalcone induces apoptosis in lung cancer cells: 3D-QSAR, docking and an in vivo/vitro assay. Sci Rep. 2017;7:10729Search in Google Scholar

[26] Menezes IR, Lopes JC, Montanari CA, Oliva G, Pavao F, Castilho MS, et al. 3D QSAR studies on binding affinities of coumarin natural products for glycosomal GAPDH of Trypanosoma cruzi. J Comput Aided Mol Des. 2003;17:277–90.Search in Google Scholar

[27] Lapinsh M, Prusis P, Gutcaits A, Lundstedt T, Wikberg JE. Development of proteo-chemometrics: a novel technology for the analysis of drug-receptor interactions. Biochim Biophys Acta. 2001;1525:180–90.Search in Google Scholar

[28] Morris GM, Lim-Wilby M. Molecular docking. Methods Mol Biol. 2008;443:365–82.Search in Google Scholar

[29] Varnek A, Baskin I. Machine learning methods for property prediction in chemoinformatics: Quo Vadis? J Chem Inf Model. 2012;52:1413–37.Search in Google Scholar

[30] Lo Y-C, Rensi SE, Torng W, Altman RB. Machine learning in chemoinformatics and drug discovery. Drug Discov Today. 2018;23:1538–46Search in Google Scholar

[31] Ali SM, Hoemann MZ, Aube J, Georg GI, Mitscher LA, Jayasinghe LR. Butitaxel analogues: synthesis and structure-activity relationships. J Med Chem. 1997;40:236–41.Search in Google Scholar

[32] Keiser M, Roth B, Armbruster B, Ernsberger P, Irwin J, Shoichet B. Relating protein pharmacology by ligand chemistry. Nat Biotechnol. 2007;25:197–206.Search in Google Scholar

[33] Lagunin A, Stepanchikova A, Filimonov D, Poroikov V. PASS: prediction of activity spectra for biologically active substances. Bioinformatics. 2000;16:747–8.Search in Google Scholar

[34] Kim S, Thiessen PA, Bolton EE, Chen J, Fu G, Gindulyte A, et al. PubChem substance and compound databases. Nucleic Acids Res. 2016;44:D1202–13Search in Google Scholar

[35] Bento AP, Gaulton A, Hersey A, Bellis LJ, Chambers J, Davies M, et al. The ChEMBL bioactivity database: an update. Nucleic Acids Res. 2014;42:D1083–90.Search in Google Scholar

[36] Marius Olah MM, Ostopovici L, Rad R, Bora A, Hadaruga N, Olah I, et al. WOMBAT: world of molecular bioactivity. In: Mannhold R, Kubinyi H, Folkers G, Oprea TI, editor(s). Chemoinformatics in drug discovery Methods and Principles in Medicinal Chemistry. Mannheim: Wiley‐VCH. 2005 May 199783527307531Search in Google Scholar

[37] Sá MS, de Menezes MN, Krettli AU, Ribeiro IM, Tomassini TC, Ribeiro Dos Santos R, et al. Antimalarial activity of physalins B, D, F, and G. J Nat Prod. 2011;74:2269–72.Search in Google Scholar

[38] Wang L, Ma C, Wipf P, Liu H, Su W, Xie X-Q. Target Hunter: an in silico target identification tool for predicting therapeutic potential of small organic molecules based on chemogenomic database. Aaps J. 2013;15:395–406.Search in Google Scholar

[39] Tan KP, Yang M, Ito S. Activation of nuclear factor (erythroid-2 like) factor 2 by toxic bile acids provokes adaptive defense responses to enhance cell survival at the emergence of oxidative stress. Mol Pharmacol. 2007;72:1380–90.Search in Google Scholar

[40] Jamkhande PG, Wattamwar AS, Pekamwar SS, Chandak PG. Antioxidant, antimicrobial activity and in silico PASS prediction of Annona reticulata Linn. root extract. Beni-Suef Univ J Basic Appl Sci. 2014;3:140–8.Search in Google Scholar

[41] Goel RK, Singh D, Lagunin A, Poroikov V. PASS-assisted exploration of new therapeutic potential of natural products. Med Chem Res. 2011;20:1509–14.Search in Google Scholar

[42] Nidhi MG, Davies J, Jenkins J. Prediction of biological targets for compounds using multiple-category Bayesian models trained on chemogenomics databases. J Chem Inf Model. 2006;46:1124–33.Search in Google Scholar

[43] L. MDDR licensed by Molecular Design. MDL Drug Data Report (MDDR). San Leandro, CA. , ed.Search in Google Scholar

[44] Kohonen T. Self-organized formation of topologically correct feature maps. Biol Cybern. 1982;43:59–69.Search in Google Scholar

[45] Schneider G, Reker D, Chen T, Hauenstein K, Schneider P, Altmann KH. Deorphaning the macromolecular targets of the natural anticancer compound doliculide. Angew Chem Int Ed. 2016;55:12408–11.Search in Google Scholar

[46] Schneider P, Schneider G. Collection of bioactive reference compounds for focused library design. QSAR Comb Sci. 2003;22:713–18.Search in Google Scholar

[47] Reker D, Rodrigues T, Schneider P, Schneider G. Identifying the macromolecular targets of de novo-designed chemical entities through self-organizing map consensus. Proc Nat Acad Sci. 2014;111:4067.Search in Google Scholar

[48] Huang T, Mi H, C.-y L, Zhao L, Zhong LL, Liu F-B, et al. MOST: most-similar ligand based approach to target prediction. BMC Bioinf. 2017;18:165.Search in Google Scholar

[49] Kurita KL, Glassey E, Linington RG. Integration of high-content screening and untargeted metabolomics for comprehensive functional annotation of natural product libraries. Proc Natl Acad Sci USA. 2015;112:11999–2004.Search in Google Scholar

[50] Navarro G, Cheng AT, Peach KC, Bray WM, Bernan VS, Yildiz FH, et al. Image-based 384-well high-throughput screening method for the discovery of skyllamycins A to C as biofilm inhibitors and inducers of biofilm detachment in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2014;58:1092–9.Search in Google Scholar

[51] Peach KC, Bray WM, Winslow D, Linington PF, Linington RG. Mechanism of action-based classification of antibiotics using high-content bacterial image analysis. Mol Biosyst. 2013;9:1837–48.Search in Google Scholar

[52] Schulze CJ, Bray WM, Woerhmann MH, Stuart J, Lokey RS, Linington RG. “Function-first” lead discovery: mode of action profiling of natural product libraries using image-based screening. Chem Biol. 2013;20:285–95.Search in Google Scholar

[53] Wong WR, Oliver AG, Linington RG. Development of antibiotic activity profile screening for the classification and discovery of natural product antibiotics. Chem Biol. 2012;19:1483–95.Search in Google Scholar

[54] Perlman ZE, Slack MD, Feng Y, Mitchison TJ, Wu LF, Altschuler SJ. Multidimensional drug profiling by automated microscopy. Science. 2004;306:1194–8.Search in Google Scholar

[55] Woehrmann MH, Bray WM, Durbin JK, Nisam SC, Michael AK, Glassey E, et al. Large-scale cytological profiling for functional analysis of bioactive compounds. Mol Biosyst. 2013;9:2604–17.Search in Google Scholar

[56] Ntie-Kang F, Onguene PA, Scharfe M, Owono LC, Megnassan E, Mbaze LM, et al. ConMedNP: a natural product library from Central African medicinal plants for drug discovery. RSC Adv. 2014;4:409–19.Search in Google Scholar

[57] Lewis AM, Mervin H, Bulusu KC, Kalash L, Svensson F, Firth MA, et al. Orthologue chemical space and its influence on target prediction. Bioinformatics. 2018;34:72–9Search in Google Scholar

[58] Kouam SF, Njonkou YL, Kuigoua GM, Ngadjui BT, Hussain H, Green IR, et al. Psorantin, a unique methylene linked dimer of vismin and kenganthranol E, two anthranoid derivatives from the fruits of Psorospermum aurantiacum (Hypericaceae). Phytochem Lett. 2010;3:185–9.Search in Google Scholar

[59] Le TT, Gardner J, Hoang-Le D, Schmidt CW, MacDonald KP, Lambley E, et al. Immunostimulatory cancer chemotherapy using local ingenol-3-angelate and synergy with immunotherapies. Vaccine. 2009;27:3053–62.Search in Google Scholar

[60] Challacombe JM, Suhrbier A, Parsons PG, Jones B, Hampson P, Kavanagh D, et al. Neutrophils are a key component of the antitumor efficacy of topical chemotherapy with ingenol-3-angelate. J Immunol. 2006;177:8123–32.Search in Google Scholar

[61] Crooks SW, Stockley RA. Leukotriene B4. Int J Biochem Cell Biol. 1998;30:173–8.Search in Google Scholar

[62] Tong W-G, Ding X-Z, Hennig R, Witt RC, Standop J, Pour PM, et al. Leukotriene B4 receptor antagonist LY293111 inhibits proliferation and induces apoptosis in human pancreatic cancer cells. Clin Cancer Res. 2002;8:3232–42.Search in Google Scholar

[63] Bingle CD, Craig RW, Swales BM, Singleton V, Zhou P, Whyte MK. Exon skipping in Mcl-1 results in a Bcl-2 homology domain 3 only gene product that promotes cell death. J Bio Chem. 2000;275:22136–46.Search in Google Scholar

[64] Nelson AW, Tilley WD, Neal DE, Carroll JS. Estrogen receptor beta in prostate cancer: friend or foe? Endocr Relat Cancer. 2014;21:T219–34.Search in Google Scholar

[65] Palmieri C, Cheng GJ, Saji S, Zelada-Hedman M, Warri A, Weihua Z, et al. Estrogen receptor beta in breast cancer. Endocr Relat Cancer. 2002;9:1–13.Search in Google Scholar

[66] Fucic A, Miškov S, Želježić D, Bogdanovic N, Katić J, Gjergja R, et al. Is the role of estrogens and estrogen receptors in epilepsy still underestimated? Med Hypotheses. 2009;73:703–5.Search in Google Scholar

[67] Bauer J, Isojarvi JI, Herzog AG, Reuber M, Polson D, Tauboll E, et al. Reproductive dysfunction in women with epilepsy: recommendations for evaluation and management. J Neurol Neurosurg Psychiatry. 2002;73:121–5.Search in Google Scholar

[68] Calabro RS, Marino S, Bramanti P. Sexual and reproductive dysfunction associated with antiepileptic drug use in men with epilepsy. Expert Rev Neurother. 2011;11:887–95.Search in Google Scholar

[69] Dupont S, Krust A, Gansmuller A, Dierich A, Chambon P, Mark M. Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes. Development. 2000;127:4277–91.Search in Google Scholar

[70] Hussein AA, Bozzi B, Correa M, Capson TL, Kursar TA, Coley PD, et al. Bioactive constituents from three vismia species. J Nat Prod. 2003;66:858–60.Search in Google Scholar

[71] Kalliokoski T, Kramer C, Vulpetti A. Quality Issues with Public Domain Chemogenomics Data. Mol Inform. 2013;32:898–905.Search in Google Scholar

[72] Gedeck P, Kramer C, Ertl P. Computational analysis of structure-activity relationships. In: Lawton G, Witty DR, editor(s). Progress in medicinal chemistry Vol. 49. Amsterdam: Elsevier. ed: 2010:113–60. .Search in Google Scholar

[73] Tetko IV, Sushko I, Pandey AK, Zhu H, Tropsha A, Papa E, et al. Critical assessment of QSAR models of environmental toxicity against Tetrahymena pyriformis: focusing on applicability domain and overfitting by variable selection. J Chem Inf Model. 2008;48:1733–46.Search in Google Scholar

[74] Kristina G, Gisbert S. Properties and architecture of drugs and natural products revisited. Curr Chem Biol. 2007;1:115–27.Search in Google Scholar

[75] Henkel. Statistical investigation into the structural complementarity of natural products and synthetic compounds. Angew Chem-Int Ed. 1999;38:643–7.Search in Google Scholar

[76] Feher M, Schmidt JM. Property distributions: Differences between drugs, natural products, and molecules from combinatorial chemistry. J Chem Inf Comput Sci. 2003;43:218–27.Search in Google Scholar

[77] Reker D, Perna AM, Rodrigues T, Schneider P, Reutlinger M, Mönch B, et al. Revealing the macromolecular targets of complex natural products. Nat Chem. 2014;6:1072–8.Search in Google Scholar

[78] Ehrman TM, Barlow DJ, Hylands PJ. Virtual screening of Chinese herbs with Random Forest. J Chem Inf Model. 2007;47:264–78.Search in Google Scholar

[79] Chamberlin SR, Blucher A, Wu G, Shinto L, Choonoo G, Kulesz-Martin M, et al. Natural product target network reveals potential for cancer combination therapies. Front Pharmacol. 2019;10:557.Search in Google Scholar

[80] Fang J, Wu Z, Cai C, Wang Q, Tang Y, Cheng F. Quantitative and systems pharmacology. 1. In silico prediction of drug-target interactions of natural products enables new targeted cancer therapy. J Chem Inf Model. 2017;57:2657–71.Search in Google Scholar

[81] Davis AP, Grondin CJ, Johnson RJ, Sciaky D, McMorran R, Wiegers J, et al. The Comparative Toxicogenomics Database: update 2019. Nucleic Acids Res. 2019;47:D948–54.Search in Google Scholar

[82] Piñero J, Queralt-Rosinach N, Bravo À, Deu-Pons J, Bauer-Mehren A, Baron M, et al. DisGeNET: a discovery platform for the dynamical exploration of human diseases and their genes. Database: J Bio Database Curation. 2015;2015:bav028–bav028.Search in Google Scholar

[83] Amberger JS, Hamosh A. Searching online mendelian inheritance in man (OMIM): A knowledgebase of human genes and genetic phenotypes. Curr Protoc Bioinf. 2017;58:1.2.1–1.2.12.Search in Google Scholar

[84] Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498–504.Search in Google Scholar

[85] Bastian M, Heymann S, Jacomy M. Gephi: An open source software for exploring and manipulating networks DOI: Association for the Advancement of Artificial Intelligence ( 2009;8.Search in Google Scholar

[86] Huang Da W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009;37:1–13.Search in Google Scholar

[87] Melak T, Gakkhar S. Comparative genome and network centrality analysis to identify drug targets of mycobacterium tuberculosis H37Rv. Biomed Res Int. 2015;2015:212061–212061.Search in Google Scholar

[88] García-Campos MA, Espinal-Enríquez J, Hernández-Lemus E. Pathway analysis: state of the art. Front Physiol. 2015;6:383.Search in Google Scholar

[89] Folger O, Jerby L, Frezza C, Gottlieb E, Ruppin E, Shlomi T. Predicting selective drug targets in cancer through metabolic networks. Mol Syst Biol. 2011;7:501.Search in Google Scholar

[90] Mohamad Zobir SZ, Mohd Fauzi F, Liggi S, Drakakis G, Fu X, Fan T-P, et al. Global mapping of traditional Chinese medicine into bioactivity space and pathways annotation improves mechanistic understanding and discovers relationships between therapeutic action (Sub)classes. Evidence-Based Complement Altern Med. 2016;2016:25.Search in Google Scholar

[91] Liggi S, Drakakis G, Koutsoukas A, Cortes-Ciriano I, Martinez-Alonso P, Malliavin T, et al. Extending in silico mechanism-of-action analysis by annotating targets with pathways: application to cellular cytotoxicity readouts. Future Med Chem. 2014;6:2029–56.Search in Google Scholar

[92] Lagunin AA, Goel RK, Gawande DY, Pahwa P, Gloriozova TA, Dmitriev AV, et al. Chemo- and bioinformatics resources for in silico drug discovery from medicinal plants beyond their traditional use: a critical review. Nat Prod Rep. 2014;31:1585–611.Search in Google Scholar

[93] Croft D, Mundo AF, Haw R, Milacic M, Weiser J, Wu G, et al. The Reactome pathway knowledgebase. Nucleic Acids Res. 2014;42:D472–7.Search in Google Scholar

[94] Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28:27–30.Search in Google Scholar

[95] Kanehisa M. The KEGG database. Novartis Found Symp. 2002;247:91–101.Search in Google Scholar

[96] Ashburner M, Ball C, Blake J, Botstein D, Butler H, Cherry J, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000;25:25–9.Search in Google Scholar

[97] Consortium TG. Expansion of the Gene Ontology knowledgebase and resources. Nucleic Acids Res. 2017;45:D331–8.Search in Google Scholar

[98] Mi H, Huang X, Muruganujan A, Tang H, Mills C, Kang D, et al. PANTHER version 11: expanded annotation data from Gene Ontology and Reactome pathways, and data analysis tool enhancements. Nucleic Acids Res. 2017;45:D183–9.Search in Google Scholar

[99] Davis AP, Grondin CJ, Johnson RJ, Sciaky D, King BL, McMorran R, et al. The Comparative Toxicogenomics Database: update 2017. Nucleic Acids Res. 2017;45:D972–8.Search in Google Scholar

Published Online: 2019-10-31

© 2020 Walter de Gruyter GmbH, Berlin/Boston